Tuesday: New drugs face daunting survival pressures


Of the thousands or even millions of possible drug compounds evaluated for their curative properties, only a few make it to market, according to SRI scientist Walter Moos, who speaks about this process at 6 p.m. Tuesday, Oct. 12, at SRI International headquarters at Middlefield Road and Ringwood Avenue in Menlo Park.

At the October Cafe Scientifique, Mr. Moos will note that the Food and Drug Administration approved 50 drugs in 1996 and only 26 in 2009.

Why? Profits at big pharmaceutical companies continue to rely on older drugs. To improve the bottom line, drug companies are cutting research and development budgets, Mr. Moos says.

Go to for directions, information on parking, and other details.

We can't do it without you.
Support local journalism.


Sorry, but further commenting on this topic has been closed.

Don't be the last to know

Get the latest headlines sent straight to your inbox every day.

Barcelona tapas restaurant coming to Palo Alto
By Elena Kadvany | 15 comments | 6,999 views

By Aldis Petriceks | 3 comments | 1,375 views

Couples: Reading List
By Chandrama Anderson | 0 comments | 814 views